First Trust Advisors LP Amphastar Pharmaceuticals, Inc. Transaction History
First Trust Advisors LP
- $101 Billion
- Q3 2024
A detailed history of First Trust Advisors LP transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 18,029 shares of AMPH stock, worth $664,188. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,029
Previous 9,710
85.67%
Holding current value
$664,188
Previous $388,000
125.26%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding AMPH
# of Institutions
286Shares Held
34.9MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$219 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$99.9 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$78.7 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$71.7 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$59.5 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.81B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...